Serum lipoprotein(a) and its relation to left ventricular thrombus in patients with acute myocardial infarction

Japanese Heart Journal

Volumn 42, Issue 1, 2001, Pages 5-14

  Celik S ^a   Baykan, M ^a   Orem C ^a   Kilinc K ^a   Orem A ^a   Erdol C ^a   Kaplan, S ^a  

^a KTU Faculty of Medicine   (Turkey)

Author keywords

Acute myocardial infarction; Left ventricular thrombus; Lipoprotein(a)

Indexed keywords

CREATINE KINASE; LIPOPROTEIN A;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL MOTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SYMPTOMATOLOGY; THROMBOSIS;

AGED; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART DISEASES; HEART VENTRICLES; HEPARIN; HUMANS; HYPERTENSION; LIPOPROTEIN(A); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING; STREPTOKINASE; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 0035083518     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.42.5     Document Type: Article

References (43)

1. Incidence of left ventricular thrombosis after acute transmural myocardial infarction: Serial evaluation by two-dimensional echocardiography
2. Left ventricular mural thrombi complicating acute myocardial infarction: Long-term follow-up with serial echocardiography
3. Mural thrombi in myocardial infarctions: Prospective evaluation by two dimensional echocardiography
4. Left ventricle I. General considerations, assessment of chamber size and function
5. Lipoprotein (a) and the risk for myocardial infarction
6. Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography
7. Serum Lp (a) level as predictor of vein graft stenosis after coronary artery bypass surgery in patients
8. The mysteries of lipoprotein (a)
9. Cys4057 of apolipoprotein (a) is essential for lipoprotein(a) assembly
10. Identification of the cysteine residue in apolipoprotein (a) that mediates extracellular coupling with apolipoprotein B100
11. Lipoprotein(a), fibrin binding, and plasminogen activation
12. A potential basis for the thrombotic risk associated with lipoprotein (a)
13. The genetics of the Lp antigen, II: A family study and proposed models of genetic control
14. Genetics of the Lp (a) lipoprotein in Japanase-Americans
15. Transient changes of serum lipoprotein (a) as an acute phase protein
16. Plasma Lipoprotein (a) and its relationship with disease activity in patients with Behçets disease
17. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography
18. Lipoprotein (a): Clinical approach to a unique atherogenic lipoprotein
19. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: The Framingham heart study
20. A new serum type system in man: The Lp system
21. Lp (a) lipoprotein and pre-β 1-lipoprotein in patients with coronary heart disease
22. A dominant role of lipoprotein (a) in the investigation and evaluation of parameters indicating the development of cerebral atherosclerosis
23. Lp (a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men
24. Studies on the kinetics of plasminogen activation by tissue plasminogen activator
25. Plasmin catalyses binding of lipoprotein (a) to immobilized fibrinogen and fibrin
26. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation
27. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: A potential mechanism in thrombogenesis
28. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
29. Lipoprotein (a) binds to human platelets and attenuates plasminogen binding and activation
30. Morphological detection and quantification of lipoprotein (a) deposition in atheromatous lesions of human aorta and coronary arteries
31. The localization of tissue factor and apolipoprotein (a) in atherosclerotic lesions of the human aorta and their relation to fibrinogen-fibrin transition
32. Lipoprotein (a) and atherogenesis
33. Plasma Lp (a) levels are increased in patients with chronic thromboembolic pulmonary hypertension
34. Lp (a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçts disease
35. Elevated serum lipoprotein (a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study
36. Lipoprotein (a) concentration is not associated with venous thromboembolism in a case control study
37. Distribution of serum lipoprotein (a) concentrations in a healthy Turkish population
38. Left ventricular thrombus in acute myocardial infarction
39. Observations on detecting left ventricular thrombus with two dimensional echocardiography: Emphasis on avoidance of false positive diagnoses
40. Long-term follow-up of left ventricular thrombus after acute myocardial infarction: A two dimensional echocardiographic study in 96 patients
41. Left ventricular mural thrombi secondary to acute myocardial infarction: Predisposing factors and embolic phenomenon
42. Early appearance of left ventricular thrombi after anterior myocardial infarction: A marker of higher in-hospital mortality in patients not treated with antithrombotic drugs